Fulgent Genetics, Inc. (FLGT) has 11 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $117K. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Kim Paul CFO and Treasurer | $40,884 | 2,087 | −1% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Hsieh Ming Chief Executive Officer | $86,039 | 4,392 | −0% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 2, 2026 | Gao Hanlin Chief Scientific Officer | −$32,885 | 1,673 | −0% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 2, 2026 | Xie Jian President and COO | −$41,809 | 2,127 | −1% | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 26, 2026 | Hsieh Ming Chief Executive Officer | $58,420 | 2,949 | −0% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free